Multiple Sclerosis Trial, Recruiting NCT07355387 Sponsor: University of Illinois at Chicago Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Recruiting

NCT07355387
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 40 and 90 years old.
  • You have been diagnosed with Multiple Sclerosis (MS).
  • You have been on the same MS treatment medication for at least 6 months without changes.
  • You have not received any physical or occupational therapy focused on balance in the past 6 months.
  • You are able to stand up from a chair on your own, even if you need to use your hands to push up.
  • Your MS affects your walking to a moderate degree, based on a specific MS walking questionnaire (confirm with trial site).
  • You do not have any other serious nerve, heart, lung, bone, or muscle conditions that affect your ability to stand or walk.
  • You speak English.
  • You are willing to take part in all study activities, including video calls via Zoom.
  • You have a reliable internet connection at home.
  • You have a helper (a "buddy") who can be present with you for all sessions.
  • You have some mild memory or thinking difficulties based on what you report about yourself.
  • You have a moderate level of MS-related disability, based on a standard MS disability rating scale (confirm with trial site).
  • You have mild memory or thinking difficulties confirmed by a cognitive test score (confirm with trial site).
  • You are not very physically active, or only moderately active, based on an activity questionnaire (confirm with trial site).
  • Your heart and breathing measurements are within safe limits during initial screening.
  • You do not have severe difficulties with speaking or understanding language.
  • Your balance meets a minimum level based on a standard balance test (confirm with trial site).
  • You are able to walk at least one block, with or without a walking aid.

Your helper buddy must also meet certain requirements:

  • Your helper buddy is 18 years old or older.
  • Your helper buddy lives close enough to you to be physically present during sessions.
  • Your helper buddy does not have any major health conditions that would stop them from helping keep you safe.
  • Your helper buddy speaks English.
  • Your helper buddy is able to attend all training and assessment sessions with you.
  • Your helper buddy is able to help with basic safety, positioning, and communicating with the research team.
  • Your helper buddy has internet access and can use Zoom.

Who may not be able to join:

  • You have had an MS relapse or worsening of symptoms in the past 3 months.
  • You have had major surgery in the past 6 months or been hospitalised in the past 3 months.
  • You experience shortness of breath while at rest, or have pain levels above 3 out of 10 that are not well controlled.
  • You have high blood pressure or diabetes that is not well controlled.
  • You have had a bone fracture in the past 6 months.
  • You have a disability that significantly limits your ability to carry out everyday activities.
  • You have epilepsy or have had uncontrolled seizures in the past year.
  • You take sedative medications that could interfere with training.
  • You take medications used to treat Alzheimer's or dementia, or are currently enrolled in another Alzheimer's clinical trial.
  • You currently take antidepressants or medications for anxiety.
  • You are considered moderate or high risk based on a standard physical activity readiness questionnaire (confirm with trial site).
  • Your thinking and memory difficulties are severe, based on a telephone screening test (confirm with trial site).
  • You are currently receiving any cognitive or physical rehabilitation treatment.
  • You use a pacemaker.
  • Your heart rate, blood pressure, or blood oxygen levels are outside safe limits at the in-person screening appointment.
  • You have severe difficulties understanding or producing speech.
  • You have a peripheral nerve injury (damage to nerves outside the brain and spinal cord).
  • Your balance score falls below a minimum level on a standard balance test (confirm with trial site).
  • You are unable to walk one block even with a walking aid.
  • You do not speak English, as the study is only delivered in English.
  • You are under 18 years old.
  • You are pregnant.
  • You are currently incarcerated or belong to another vulnerable population as defined by the trial (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 3124139772

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Illinois at Chicago
Registry
ClinicalTrials.gov
Start date
24 November 2025
Est. completion
24 November 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Safety: occurrence of adverse events; Adherence; Change in Physical Function measured by Short Physical Performance Battery; Change in Walking Function: Dynamic Gait Index (DGI); Change in Walking endurance: Timed 25-Foot Walk; Change in information processing speed; Change in verbal learning and memory; Change in visuospatial learning and memory; Change in Dual-task balance cost; Change in Community Mobility: University of Alabama Birmingham (UAB) Questionnaire; Change in Community Mobility: Accelerometer; Change in Quality of Life: Multiple Sclerosis Impact Scale (MSIS-29); Change in Balance...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov